Therapeutic nipple‐sparing mastectomy: a scoping review of oncologic safety and predictive factors for in‐breast recurrence
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.19343 ↗Kurz gefasst
Scoping Review in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Sebastian Spillane und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Nipples, Mastectomy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Breast cancer is a common disease, with mastectomy remaining necessary in a proportion of patients. Nipple‐sparing mastectomy with reconstruction improves cosmesis compared with traditional nipple‐sacrificing techniques. However, concerns regarding increased rates of local recurrence in the retained skinfold and nipple‐areolar complex exist. The aim of this scoping review is to assess the incidence of in‐breast recurrence after therapeutic nipple‐sparing mastectomy and analyze predictors of recurrence. A systematic search was conducted using Ovid MEDLINE(R) ALL and Cochrane Library databases, with keywords related to ‘nipple‐sparing mastectomy’ and ‘local recurrence’. Studies that reported rates of in‐breast recurrence for patients who underwent therapeutic nipple‐sparing mastectomy with immediate breast reconstruction were included. 1465 search results were identified, with 17 studies meeting eligibility criteria. The included studies encompassed 7280 patients, with median follow‐up time ranging from 28 to 156 months. Nipple‐areolar complex, local, regional and locoregional recurrence ranged from 0% to 4.8%, 0% to 10.0%, 0.4% to 3.9% and 1.7% to 24.1%, respectively. A positive linear correlation between recurrence rates and follow‐up duration of the included studies was observed. Predictive factors included tumour to nipple distance less than 2 cm, disease stage, molecular subtype and lymphovascular invasion. Nipple‐sparing mastectomy is oncologically safe with careful patient selection. Long‐term follow‐up of patients who undergo nipple‐sparing mastectomy may be necessary due to the high rate of late recurrence observed in the included studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Breast Surgery, St Vincent's Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Sebastian Spillane
Zitieren
APA
Spillane, S., Baker, C., & Lippey, J. (2025). Therapeutic nipple‐sparing mastectomy: a scoping review of oncologic safety and predictive factors for in‐breast recurrence. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19343
Vancouver
Spillane S, Baker C, Lippey J. Therapeutic nipple‐sparing mastectomy: a scoping review of oncologic safety and predictive factors for in‐breast recurrence. ANZ Journal of Surgery. 2025. doi:10.1111/ans.19343
BibTeX
@article{Spillane2025,
author = {Spillane, Sebastian and Baker, Caroline and Lippey, Jocelyn},
title = {Therapeutic nipple‐sparing mastectomy: a scoping review of oncologic safety and predictive factors for in‐breast recurrence},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.19343}
}
EUVIMED